Autologous bone marrow versus non-mobilized peripheral blood stem cell transplantation for lymphoid malignancies: a prospective, comparative trial.

@article{Weisdorf1997AutologousBM,
  title={Autologous bone marrow versus non-mobilized peripheral blood stem cell transplantation for lymphoid malignancies: a prospective, comparative trial.},
  author={Daniel J. Weisdorf and C M Verfaille and Wesley J. Miller and Bruce R Blazar and Emily Perry and Xiao-Ou Shu and Keith A. Daniels and Peter Hannan and Norma K. C. Ramsay and John H. Kersey and Philip B Mcglave},
  journal={American journal of hematology},
  year={1997},
  volume={54 3},
  pages={
          202-8
        }
}
Autologous transplantation using bone marrow stem cells (BMSC) or peripheral blood stem cells (PBSC) is widely used for non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD). We report a randomized, comparative trial comparing BMSC vs. non-mobilized PBSC for responsive NHL or HD. Patients randomized to BMSC (n = 13) vs. PBSC (n = 15) had more rapid neutrophil recovery (median 23 vs. 30 days), RBC independence (25 vs. 62 days), platelet independence (24 vs. 54 days), and shorter hospital stay… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-3 of 3 extracted citations

Bone Marrow Versus Peripheral Blood Stem Cell Transplant in Lymphoma: A Systematic Review and Meta-Analysis.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation • 2018
View 7 Excerpts
Highly Influenced